학술논문
TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial
Document Type
Article
Author
Quoix, Elisabeth; Lena, Hervé; Losonczy, Gyorgy; Forget, Frédéric; Chouaid, Christos; Papai, Zsolt; Gervais, Radj; Ottensmeier, Christian; Szczesna, Aleksandra; Kazarnowicz, Andrzej; Beck, Joseph T; Westeel, Virginie; Felip, Enriqueta; Debieuvre, Didier; Madroszyk, Anne; Adam, Julien; Lacoste, Gisèle; Tavernaro, Annette; Bastien, Bérangère; Halluard, Céline; Palanché, Tania; Limacher, Jean-Marc
Source
In The Lancet Oncology February 2016 17(2):212-223
Subject
Language
ISSN
1470-2045